Thirty Madison
Thirty Madison is a New York-based virtual-first telehealth company that delivers specialist care for chronic conditions through three consumer brands — Keeps (men's hair loss), Nurx (women's health), and Cove (migraine) — via an integrated pharmacy and nationwide clinician platform, acquired by Remedy Meds in 2025.
- Company typePrivate
- Founded2017
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Thirty Madison does
Thirty Madison was a New York-based, virtual-first specialized healthcare company founded in 2017 that delivered specialist-level care for chronic conditions directly to consumers through a portfolio of dedicated sub-brands. Its three operating brands — Keeps (men's hair loss), Nurx (women's health, including contraception, STI testing, and migraine), and Cove (migraine management) — each addressed a specific clinical vertical under a shared platform architecture comprising virtual consultations, nationwide clinician coverage, insurance integration, and an in-house pharmacy fulfillment network for prescription medications. The company monetized through subscription-based, recurring telehealth and pharmacy revenue streams and pursued a direct-to-consumer go-to-market motion with no disclosed enterprise customers.
The underlying technology stack combined telemedicine workflows with integrated pharmacy logistics rather than proprietary AI; the platform's primary differentiators were operational — vertical specialization, brand-led consumer acquisition, and end-to-end medication fulfillment. Thirty Madison scaled from a $7.5 million Series A in 2017 to unicorn status in June 2021 via a $140 million Series C led by HealthQuest Capital, and expanded its women's health vertical through the February 2022 acquisition of Nurx. In September 2025, Remedy Meds agreed to acquire Thirty Madison in an all-stock transaction valued at over $500 million (expected close Q4 2025), combining Keeps, Nurx, and Cove with Remedy Meds' GLP-1 weight loss offerings into a multi-brand telehealth and pharmacy platform with combined annual revenue exceeding $670 million and both entities reported as strongly profitable at announcement.
Thirty Madison firmographics
Firmographics- Name
- Thirty Madison
- Website
- https://www.thirtymadison.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Short description
- Thirty Madison is a New York-based virtual-first telehealth company that delivers specialist care for chronic conditions through three consumer brands — Keeps (men's hair loss), Nurx (women's health), and Cove (migraine) — via an integrated pharmacy and nationwide clinician platform, acquired by Remedy Meds in 2025.
- Ownership category
- akta.pro rank
Thirty Madison industry classification
Industry- Product category
- Consumer Telehealth / Virtual Specialty Care
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Membership/Subscription Concierge Virtual Care (HLALAAAH)
Keywords
Where Thirty Madison is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Thirty Madison business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Virtual Specialty Care Services: Subscription-based telehealth services across multiple verticals including women's health, men's health, migraine, and weight management, generating over $670 million in combined annual revenue with the Remedy Meds acquisition
- Pharmacy and Medication Fulfillment: Integrated pharmacy services providing medication fulfillment for prescriptions issued through the telehealth platform, part of the combined entity's $670M+ revenue base
Go-to-market motion1 record
Distribution channels1 record
Thirty Madison product offering
Product offeringCore offering
Thirty Madison provides direct-to-consumer virtual specialty care for chronic conditions through three branded platforms: Keeps for men's hair loss, Nurx for women's health, and Cove for migraine management. The platform connects patients with nationwide clinicians for consultations and prescriptions, then fulfills medications through an integrated pharmacy delivery network with insurance integration.
Product overview
Thirty Madison is a multi-brand virtual care and pharmacy platform offering specialized telehealth services across three distinct sub-brands: Keeps (men's hair loss), Nurx (women's health), and Cove (migraine management). The platform provides virtual specialty care with nationwide clinician coverage, insurance integration, and pharmacy fulfillment capabilities. The company was acquired by Remedy Meds in a deal valued at over $500 million, combining these brands with Remedy Meds' GLP-1 weight loss offerings to create a unified multi-brand ecosystem spanning women's, men's, and metabolic health.
Differentiator
Problem solved
Functional benefit
Brands
- Keeps: Men's hair loss brand
- Nurx
- Cove
Products and services
- Keeps Keeps is a direct-to-consumer men's hair loss treatment platform offering prescription and over-the-counter solutions for male pattern baldness, including finasteride and minoxidil, delivered through virtual consultations and pharmacy fulfillment.
- Nurx Nurx is a women's health platform providing telemedicine consultations and prescriptions for birth control, STI testing, migraine treatment, and other women's health needs, with at-home delivery of medications and tests.
- Cove Cove is a migraine management platform offering acute and preventive migraine treatments, including prescription medications and personalized care plans, delivered through virtual consultations and pharmacy fulfillment.
Quantifiable outcome
- Combined entity exceeds $670 million in annual revenue with strong profitability
Companies that use Thirty Madison
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Thirty Madison technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Thirty Madison partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Remedy MedsflagshipAcquired Thirty Madison in September 2025 for over $500 million in an all-stock transaction. The deal combines Remedy Meds' weight loss and GLP-1 offerings with Thirty Madison's women's health, migraine, and men's hair loss brands, creating a multi-brand telehealth ecosystem with over $670 million in combined annual revenue.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Thirty Madison competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Public DTC telehealth company (NYSE: HIMS) offering subscription-based virtual care for hair loss, women's health, mental health, sexual health, and now weight loss via GLP-1s. Closest direct competitor — overlapping brands, channels, and customer base with Keeps, Nurx, and Cove.
- Ro: DTC telehealth and pharmacy company operating across men's health (Roman), women's health (Ro Body), weight loss (Ro GLP-1 program), and smoking cessation. Directly comparable multi-brand DTC telehealth-plus-pharmacy model competing for the same chronic-condition patients.
- Maven Clinic: Virtual care platform focused on women's and family health (fertility, pregnancy, postpartum, menopause). Overlaps with Thirty Madison's Nurx brand in women's health specialty and competes for the same chronic-condition virtual care category.
- Curology: DTC telehealth company providing prescription skincare through an online consultation, custom-compounded treatment, and subscription model. Closely comparable in DTC telehealth-plus-subscription-pharmacy mechanics, though focused on dermatology.
Emerging players
- Wisp: DTC telehealth startup focused on women's health — including birth control, UTI treatment, and herpes — competing directly with Nurx in women's reproductive and sexual health. Smaller scale and more limited brand portfolio.
- Cerebral: DTC telehealth platform for mental health (anxiety, depression, ADHD) including prescription medication management. Comparable subscription telehealth-plus-pharmacy model targeting a different chronic-condition vertical.
- Done. DTC telehealth provider focused on adult ADHD diagnosis and stimulant medication management. Comparable virtual-first, subscription-based specialty care and pharmacy fulfillment model in a chronic-condition vertical.
Broad incumbents
- Teladoc Health: Large publicly-traded telehealth incumbent offering general medical, mental health, chronic condition management, and specialist virtual care to consumers, employers, and payers. Broader portfolio than Thirty Madison but overlaps in DTC and chronic-condition delivery.
- Amwell: Enterprise-focused telehealth platform offering virtual urgent care, behavioral health, and chronic condition management to health systems, payers, and employers. Adjacent competitor providing overlapping specialty chronic-condition capabilities at scale.
Others
- Remedy Meds: Direct-to-consumer telehealth and pharmacy platform focused on weight loss and GLP-1 medications. Acquirer of Thirty Madison and now combined with it — relevant as both a peer and as the parent entity defining the post-2025 combined platform.
Market position
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Thirty Madison social profiles
Digital presenceThirty Madison financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thirty Madison leadership team
Management profileNumber of profiles
Profiles8 records
Thirty Madison funding detail
Funding detailFunding overview
Funding rounds8 records
Investors25 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thirty Madison M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thirty Madison
What does Thirty Madison do?
Thirty Madison provides direct-to-consumer virtual specialty care for chronic conditions through three branded platforms: Keeps for men's hair loss, Nurx for women's health, and Cove for migraine management. The platform connects patients with nationwide clinicians for consultations and prescriptions, then fulfills medications through an integrated pharmacy delivery network with insurance integration.
Is Thirty Madison a public or private company?
Thirty Madison is a private company. It is classified as venture growth investor backed and is currently acquired.
When was Thirty Madison founded?
Thirty Madison was founded in 2017. It employs 501 to 1,000 people.
Where is Thirty Madison based?
Thirty Madison is headquartered in New York, United States, in the North America region.
How does Thirty Madison make money?
Two revenue lines are on record. Virtual Specialty Care Services are the primary driver. The others are pharmacy and Medication Fulfillment.
Who are Thirty Madison's main competitors?
Direct peers on record are Hims & Hers Health, Ro, Maven Clinic and Curology. Emerging players are Wisp, Cerebral and Done.. Broad incumbents are Teladoc Health and Amwell. Remedy Meds is listed as an others.
Does Thirty Madison have an API?
No public API is recorded for Thirty Madison.
What industry is Thirty Madison in?
Thirty Madison's product category is Consumer Telehealth / Virtual Specialty Care. Its primary akta.pro industry code is HLALAAAH, Membership/Subscription Concierge Virtual Care. Its NAICS code is 6211 and its SIC code is 8000.